US Patent Issued to The Regents of the University of California on Dec. 9 for "Tumor selective macropinocytosis-dependent rapidly internalizing antibodies" (California Inventor)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,490, issued on Dec. 9, was assigned to The Regents of the University of California (Oakland, Calif.).

"Tumor selective macropinocytosis-dependent rapidly internalizing antibodies" was invented by Bin Liu (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for identifying and selecting antibodies that are internalized into cells via the macropinocytosis pathway. Additionally antibodies that are internalized via this pathway are provided as well as immunoconjugates comprising such antibodies."

The patent was filed on Aug. 3, 2022, under Application No. 17/880,556.

*For further information, including images, charts and t...